cetylpyridinium chloride anhydrous has been researched along with Fasciitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boda, DP; Boothby, IC; Chan, JD; Clancy, S; Cohen, JN; Habrylo, I; Harris, HW; Kinet, MJ; Kwan, EY; Lowe, MM; McCalmont, TH; Molofsky, AB; Neuhaus, IM; Pauli, M; Rosenblum, MD; Yates, AE | 1 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and Fasciitis
| Article | Year |
|---|---|
Early-life inflammation primes a T helper 2 cell-fibroblast niche in skin.
Topics: Animals; Animals, Newborn; Cytokines; Eosinophilia; Fasciitis; Fibroblasts; Fibrosis; Health; Humans; Inflammation; Interleukin-13 Receptor alpha1 Subunit; Male; Mice; Skin; Stem Cell Niche; T-Lymphocytes, Regulatory; Th2 Cells; Wound Healing | 2021 |